The short answer
The need to separate calcium carbonate from diflunisal is uncertain. Ask your pharmacist to review the exact product and frequency, since evidence for other antacids does not establish a calcium-specific schedule.
What this answer covers
Oral calcium carbonate supplements or antacids with prescription oral diflunisal. Distinguish exact salt, antacid formulation and regular versus occasional use.
- Supplement or preparation
- Calcium carbonate
- Medication ingredient
- diflunisal
The drug label has a general antacid caution
Diflunisal labeling says antacids may lower drug levels, particularly with continuous use. It does not establish a calcium-carbonate-specific effect or a universal separation interval. A calcium supplement and a combination antacid also may have different ingredients and dosing patterns.
Different antacids had different effects
A small original diflunisal study found lower exposure with fasting aluminum hydroxide, a different result with magnesium hydroxide, and no detectable effect with the tested fed aluminum preparations. Calcium carbonate was not tested. These results should not be converted into a numeric effect for your calcium product.
Have the pharmacist check the formulation
Show the full label, including magnesium or aluminum ingredients, and explain whether you take it for calcium intake or frequent heartburn. The available evidence does not justify automatically stopping prescribed calcium, changing diflunisal doses or applying an untested two-hour rule.
Do not overlook ongoing stomach symptoms
Regular antacid need during diflunisal treatment deserves review. Diflunisal can cause ulcers and GI bleeding, and an antacid is not proof of protection. Seek urgent help for vomiting blood or black, tarry stools, and report persistent stomach pain to your prescriber.
Evidence and practical considerations
Timing & monitoring
A calcium-carbonate-specific need to separate or avoid diflunisal has not been established by the inspected evidence.
- Exact scope
- Oral calcium carbonate supplements or antacids with prescription oral diflunisal. Distinguish exact salt, antacid formulation and regular versus occasional use. with Exact diflunisal RxCUI 3393 IN, confirmed by current RxNorm. Prescription oral tablets; not aspirin, and not a class-average NSAID effect.
- Medication form and route
- Oral
What remains uncertain
- Exact label warns generally about antacids, but the inspected comparative trial tested aluminum and magnesium hydroxides, not calcium carbonate. An archival antacid SmPC lead was inaccessible and is not evidence.
Factors that may matter: Exact preparation and dose; Fasting versus fed dosing; Bleeding and ulcer history; Other medicines.
Read the supporting source summaries
Source 1: Current prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Prescription oral diflunisal users and healthy-volunteer pharmacology studies.
Diflunisal has dose-dependent reversible platelet effects. At 500 mg twice daily effects were slight; 250 mg twice daily had no measurable effect in a short study. Serious GI bleeding and ulcers remain labeled risks. Antacids may lower levels, especially with continuous use.
How this applies: Exact current drug label. Exact diflunisal RxCUI 3393 IN, confirmed by current RxNorm. Prescription oral tablets; not aspirin, and not a class-average NSAID effect.
Not proof of each supplement combination. Short healthy-volunteer fecal blood-loss findings do not establish long-term GI safety. Aspirin has different platelet pharmacology. No universal antacid separation interval.
Source 2: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 12 healthy men.
Fasting aluminum hydroxide lowered AUC 26% and peak 46%. Fed aluminum hydroxide or the tested fed aluminum/magnesium mixture had no detectable effect. Fasting magnesium hydroxide increased early concentrations and AUC by 10%.
How this applies: Exact drug where specified; other-drug and supplement-only findings remain indirect.
Abstract-only, single doses and small sample. Not calcium carbonate. No long-term pain endpoint or trial of hours-apart dosing.
Source 3: Medication terminology
rxnav.nlm.nih.gov · Source check Sep 10, 2026
Population: Terminology record.
Diflunisal, IN.
How this applies: Exact identity.
No clinical evidence.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Sources checked and article drafted. | |
| Research summary published |
Article revision: f31c2c75e8d07a56
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.